Why the study?
Antidepressants may increase bleeding risk, particularly in patients with other risk factors, but guidance on prescribing serotonin reuptake inhibitors and other antidepressants in this setting is limited.
How should clinicians manage the initiation, discontinuation, or dose adjustment of antidepressants in patients at risk for bleeding?
How should clinicians manage the initiation, discontinuation, or dose adjustment of antidepressants in patients at risk for bleeding?
This expert consensus provides a clinical decision algorithm to guide the safe prescribing, dose adjustment, or discontinuation of antidepressants in patients with elevated bleeding risk.
Answers are grounded in this paper and cite their sources.
Guides safer antidepressant prescribing in patients at bleeding risk; extends evidence synthesis into consensus recommendations and a decision algorithm.
OBJECTIVE Exposure to antidepressants, particularly agents that work through serotonin-reuptake inhibition, may increase potential for bleeding, especially among patients with other bleeding risk factors. There is limited guidance for clinicians in the use of serotonin reuptake inhibitors (SRIs) and other antidepressants in the setting of increased bleeding risk. METHODS A PubMed literature search was conducted for English-language articles (1992-2024) examining the bleeding risk associated with antidepressants. Physicians from the Association of Medicine and Psychiatry then convened to develop consensus recommendations. RESULTS Consensus recommendations were established for managing antidepressant use in patients with medical and psychiatric comorbidities. Additionally, a clinical decision algorithm was created to assist clinicians in assessing the appropriateness of antidepressant prescribing in patients at risk for bleeding. CONCLUSIONS The proposed algorithm can aid clinicians in determining whether antidepressant (including SRI) initiation, discontinuation, or dose adjustment should be considered for patients susceptible to bleeding. These guidelines preserve a role for clinical judgment in selection of treatments that balance the risks and benefits, which may be particularly relevant for patients with complex medical and psychiatric comorbidities. Additional studies are needed to better guide clinical decision making.
No takes yet. Share an insight, caveat, or question.
Robbins-Welty et al. (2026) conducted a review in Antidepressant use in patients with bleeding risk. Antidepressants (including serotonin reuptake inhibitors) was evaluated on Bleeding risk associated with antidepressants. Expert consensus recommendations and a clinical decision algorithm were developed to assist clinicians in managing antidepressant prescribing for patients at risk for bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: